Last update 01 Nov 2024

Recombinant Fifteen Valent Human Papillomavirus Vaccine(E.coli)(Liaoning Chengda Biotechnology)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Genetically engineered subunit vaccine
Synonyms
15价HPV疫苗（成大生物）
Target-
Mechanism
Immunostimulants
Therapeutic Areas
Infectious Diseases
Active Indication
Human Papillomavirus Infection
Inactive Indication-
Originator Organization
Liaoning Chengda Biotechnology Co. Ltd.Liaoning Chengda Biotechnology Co. Ltd.
Active Organization
Liaoning Chengda Biotechnology Co. Ltd.Liaoning Chengda Biotechnology Co. Ltd.Beijing Health Guard Biotechnology, Inc.Beijing Health Guard Biotechnology, Inc.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Recombinant Fifteen Valent Human Papillomavirus Vaccine(E.coli)(Liaoning Chengda Biotechnology)
CTR20241041 / Active, not recruitingPhase 1
评价在 9-45 周岁健康女性受试者中接种重组十五价人乳头瘤病毒疫苗 （大肠埃希菌）的安全性、耐受性和免疫原性的随机、盲法、安慰剂和阳 性对照的Ⅰ期临床试验
[Translation] A randomized, blinded, placebo- and positive-controlled phase I clinical trial to evaluate the safety, tolerability, and immunogenicity of a recombinant 15-valent human papillomavirus vaccine (Escherichia coli) in healthy female subjects aged 9-45 years
100 Clinical Results associated with Recombinant Fifteen Valent Human Papillomavirus Vaccine(E.coli)(Liaoning Chengda Biotechnology)
Login to view more data
100 Translational Medicine associated with Recombinant Fifteen Valent Human Papillomavirus Vaccine(E.coli)(Liaoning Chengda Biotechnology)
Login to view more data
100 Patents (Medical) associated with Recombinant Fifteen Valent Human Papillomavirus Vaccine(E.coli)(Liaoning Chengda Biotechnology)
Login to view more data
100 Deals associated with Recombinant Fifteen Valent Human Papillomavirus Vaccine(E.coli)(Liaoning Chengda Biotechnology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Human Papillomavirus InfectionPhase 1
CN
Liaoning Chengda Biotechnology Co. Ltd.Liaoning Chengda Biotechnology Co. Ltd.
30 Mar 2024
Human Papillomavirus InfectionPhase 1
CN
Beijing Health Guard Biotechnology, Inc.Beijing Health Guard Biotechnology, Inc.
30 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free